Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fastidious Detection of Circulating Tumor DNA Mutations in Residual Breast Cancer Disease for Ultimate Analytical Sensitivity and Specificity.

Clinical chemistry - 1 Jul 2020

Chiu Rossa W K

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Circulating Tumor DNA
Share to Mutation
Share to Neoadjuvant Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm, Residual

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 32215639
DOI: 10.1093/clinchem/hvaa068

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fastidious Detection of Circulating Tumor DNA Mutations in Residual Breast Cancer Disease for Ultimate Analytical Sensitivity and Specificity.PMID 32215639Read ↗

Clinical application of circulating tumor DNA in breast cancer.Semantic proximity Read ↗

Circulating Tumor DNA in Breast Cancer: Current and Future Applications.Semantic proximity Read ↗

Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis.Semantic proximity Read ↗

Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood.Semantic proximity Read ↗

Development of a novel NGS methodology for ultrasensitive circulating tumour DNA detection as a tool for early-stage breast cancer diagnosisSemantic proximity Read ↗

The biological and technical challenges facing utilizing circulating tumor DNA in non-metastatic breast cancer patientsSemantic proximity Read ↗

The applications of plasma cell-free DNA in cancer detection: Implications in the management of breast cancer patients.Semantic proximity Read ↗

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring.Semantic proximity Read ↗

Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance.Semantic proximity Read ↗

Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer DetectionSemantic proximity Read ↗

Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNASemantic proximity Read ↗

Clinical applications of circulating tumor DNA in monitoring breast cancer drug resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.